Abstract
Neguine Rezaii
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial
10.1001/jama.2023.13239 · 2023
Lecanemab in early Alzheimer’s disease
10.1056/nejmoa2212948 · 2023
Advancing early detection of Alzheimer disease in the primary care setting in the United States
10.1212/cpj.0000000000200568 · 2026
“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · 1975
The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment
10.1111/j.1532-5415.2005.53221.x · 2005
Missed and delayed diagnosis of dementia in primary care: Prevalence and contributing factors
10.1097/wad.0b013e3181a6bebc · 2009
Factors associated with cognitive evaluations in the United States
10.1212/wnl.0000000000001096 · 2015
Caring for patients with dementia: The GP perspective
10.1080/713649963 · 2000
An autonomous agentic workflow for clinical detection of cognitive concerns using large language models
10.1038/s41746-025-02324-4 · 2026
Voiceprints of cognitive impairment: Analyzing digital voice for early detection of Alzheimer’s and related dementias
10.1038/s44400-025-00040-0 · 2025
No additional external references are available.